Stocks
Axsome Therapeutics (AXSM) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -108.5 | -117.2 | -145.7 | -128.7 | -93.9 | -71.0 | ||
| Changes by years, y/y, % | +38% | +8% | +24% | -12% | -27% | +3.6% | |||
Axsome Therapeutics. FCF, bln rub
Axsome Therapeutics. FCF, changes, %
Axsome Therapeutics. FCF, sum by quarters, bln rub
Axsome Therapeutics (AXSM) FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF, bln rub | ? | -43.7 | -32.4 | 0.988 | -18.7 | -20.8 | -71.0 | |
| Changes by years, y/y, % | -18% | +8% | -105% | -29% | -52% | |||
| Changes by quarters, q/q, % | +67% | -26% | -103% | -1 995% | +11% | |||
